AU6466990A - New intermediates of pyridone, process and intermediates of preparation,their application as medicaments and compositions containing them - Google Patents

New intermediates of pyridone, process and intermediates of preparation,their application as medicaments and compositions containing them

Info

Publication number
AU6466990A
AU6466990A AU64669/90A AU6466990A AU6466990A AU 6466990 A AU6466990 A AU 6466990A AU 64669/90 A AU64669/90 A AU 64669/90A AU 6466990 A AU6466990 A AU 6466990A AU 6466990 A AU6466990 A AU 6466990A
Authority
AU
Australia
Prior art keywords
optionally substituted
image
alkyl
intermediates
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU64669/90A
Other versions
AU642434B2 (en
Inventor
Francois Clemence
Michel Fortin
Odile Le Martret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU6466990A publication Critical patent/AU6466990A/en
Application granted granted Critical
Publication of AU642434B2 publication Critical patent/AU642434B2/en
Assigned to HOECHST MARION ROUSSEL reassignment HOECHST MARION ROUSSEL Alteration of Name(s) in Register under S187 Assignors: ROUSSEL-UCLAF
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Alteration of Name(s) in Register under S187 Assignors: HOECHST MARION ROUSSEL
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compounds of the formula (I): <IMAGE> in which: - either E and G form <IMAGE> which represents: <IMAGE> in which R represents hydrogen, alkyl, alkenyl or alkynyl, which is optionally substituted, free carboxyl, esterified carboxyl or carboxylic salt, acyl, alkoxy, hydroxy, amino, alkylamino, dialkylamino, acyloxy, cyano, carbamoyl or halogen -- Y represents carbocyclic aryls, heteromonocyclic aryls or condensed heterocyclic aryls which are optionally substituted, <IMAGE> - or E represents -CO2R3, in which R3 represents hydrogen or alkyl and G represents <IMAGE> -- A represents: - either a carbocyclic radical which is optionally substituted, - or <IMAGE> where B represents: - hydrogen, - aryl or arylalkyl, or - cycloalkyl, which are optionally substituted, - alkyl, alkenyl, alkynyl or alkyloxy which are optionally substituted, -- R1 and R2 represent hydrogen, alkyl, alkenyl or alkynyl which are optionally substituted, or R1 and R2 form with the nitrogen atom a 5-, 6- or 7-membered heterocycle optionally containing another heteroatom and optionally substituted, their preparation and their use as medicines.
AU64669/90A 1989-10-17 1990-10-17 New intermediates of pyridone, process and intermediates of preparation,their application as medicaments and compositions containing them Ceased AU642434B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8913545 1989-10-17
FR8913545A FR2653123B1 (en) 1989-10-17 1989-10-17 NEW PYRIDONE DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Publications (2)

Publication Number Publication Date
AU6466990A true AU6466990A (en) 1991-04-26
AU642434B2 AU642434B2 (en) 1993-10-21

Family

ID=9386472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64669/90A Ceased AU642434B2 (en) 1989-10-17 1990-10-17 New intermediates of pyridone, process and intermediates of preparation,their application as medicaments and compositions containing them

Country Status (16)

Country Link
US (3) US5356907A (en)
EP (1) EP0437120B1 (en)
JP (1) JP3032274B2 (en)
KR (1) KR0169717B1 (en)
AT (1) ATE125796T1 (en)
AU (1) AU642434B2 (en)
CA (1) CA2027702A1 (en)
DE (1) DE69021355T2 (en)
DK (1) DK0437120T3 (en)
ES (1) ES2075180T3 (en)
FR (1) FR2653123B1 (en)
GR (1) GR3017022T3 (en)
HU (1) HU208007B (en)
IE (1) IE69342B1 (en)
RU (1) RU2078082C1 (en)
ZA (1) ZA907736B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714291B1 (en) * 1993-12-24 1996-03-01 Roussel Uclaf Application of pyridone derivatives as anesthetic drugs.
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (en) 1996-09-27 1998-04-02 Hoechst Ag Antifungal agents with high drug release
TW200508224A (en) * 2003-02-12 2005-03-01 Bristol Myers Squibb Co Cyclic derivatives as modulators of chemokine receptor activity
US9012494B2 (en) 2004-05-07 2015-04-21 Janssen Pharmaceutica N.V. Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
MY141198A (en) 2004-08-30 2010-03-31 Janssen Pharmaceutica Nv Tricyclic adamantylamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
KR101197674B1 (en) 2004-08-30 2012-11-07 얀센 파마슈티카 엔.브이. N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
DE602005017159D1 (en) 2004-08-30 2009-11-26 Janssen Pharmaceutica Nv OXYSTEROID DEHYDROGENASE INHIBITORS
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058986A (en) * 1962-10-16 N-ammoalkyl-x-phenyl-x-lower alkyl-z-
BE571915A (en) * 1957-10-10
US3213098A (en) * 1963-08-30 1965-10-19 Upjohn Co Amino substituted 3h-azepines and their preparation
US3950393A (en) * 1973-04-13 1976-04-13 Boehringer Ingelheim Gmbh Aminobenzyl-amides and salts thereof
GB1532957A (en) * 1974-11-04 1978-11-22 Glaxo Lab Ltd Bis(aminomethyl)naphthalene derivatives
EP0021552B1 (en) * 1977-12-22 1983-01-26 JOHN WYETH &amp; BROTHER LIMITED Hexahydroazepine, piperidine and pyrrolidine derivatives and processes for preparing them
DK704488D0 (en) * 1988-12-19 1988-12-19 Novo Industri As NEW N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS
ES2043943T3 (en) * 1988-05-20 1994-01-01 Zambon Spa PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH CENTRAL ANALGESIC ACTIVITY.

Also Published As

Publication number Publication date
DE69021355T2 (en) 1996-01-25
HU208007B (en) 1993-07-28
EP0437120B1 (en) 1995-08-02
US5356907A (en) 1994-10-18
JPH03133957A (en) 1991-06-07
KR910007912A (en) 1991-05-30
IE69342B1 (en) 1996-09-04
AU642434B2 (en) 1993-10-21
ATE125796T1 (en) 1995-08-15
DK0437120T3 (en) 1996-04-09
US5395843A (en) 1995-03-07
KR0169717B1 (en) 1999-01-15
GR3017022T3 (en) 1995-11-30
ZA907736B (en) 1991-11-27
FR2653123B1 (en) 1992-01-17
JP3032274B2 (en) 2000-04-10
CA2027702A1 (en) 1991-04-18
US5559130A (en) 1996-09-24
ES2075180T3 (en) 1995-10-01
HUT55379A (en) 1991-05-28
FR2653123A1 (en) 1991-04-19
DE69021355D1 (en) 1995-09-07
HU906459D0 (en) 1991-04-29
EP0437120A1 (en) 1991-07-17
IE903704A1 (en) 1991-04-24
RU2078082C1 (en) 1997-04-27

Similar Documents

Publication Publication Date Title
LU91362I2 (en) Paliperidone and its pharmaceutically acceptable derivatives (INVEGA)
IE940525L (en) Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
NZ218786A (en) 1,4 disubstituted piperidine derivatives and pharmaceutical compositions
MY100343A (en) Amide derivative and external medicament comprising same
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
ES474288A1 (en) 3-Substituted-6-substituted-7-oxo-1-azabicyclo (3.2.0)-hept-2-ene-2-carboxylic acid, its preparation and pharmaceutical compositions containing it.
IL108194A0 (en) Hexahydronaphthalene ester derivatives, pharmaceutical compositions containing the same and processes for the preparation therof
WO1987006226A3 (en) Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
ATE60579T1 (en) PYRROLIDINAMIDE DERIVATIVES WITH ANTIPROPYLENE ENDOPEPTIDASE ACTIVITY, COMPOSITIONS CONTAINING THEM, PROCESSES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM.
AU642434B2 (en) New intermediates of pyridone, process and intermediates of preparation,their application as medicaments and compositions containing them
IL77452A0 (en) Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
GR3023107T3 (en) New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them.
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
AU1507888A (en) New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
AU643759B2 (en) Urea derivatives and salts thereof, pharmaceutical compositions containing the same, and methods for producing the same
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
MY106235A (en) New 2 - carbonyl substituted n, n&#39;&#39; -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
IE810901L (en) Naphthotriazoles.
AU4012393A (en) New diacylglycerol nicotinates, process for their preparation and pharmaceutical compositions which contain them
HUT45059A (en) Process for producing abeoergoline derivatives
FI860098A (en) NYA PIPERAZINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH PHARMACEUTICAL COMPOSITION SOM INNEHAOLLER DESSA FOERENINGAR SOM AKTIV INGREDIENS.
ES2130392T3 (en) PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID.
AU2742288A (en) Novel compound effective as cerebral insufficiency improver

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER OWNER WAS: HOECHST MARION ROUSSEL

MK14 Patent ceased section 143(a) (annual fees not paid) or expired